The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Universal Definition and Classification of Heart Failure
Open accessAbstract
In this document, we propose a universal definition of heart failure (HF) as the following: HF is a clinical syndrome with symptoms and or signs caused by a structural and/or functional cardiac abnormality and corroborated by elevated natriuretic peptide levels and or objective evidence of pulmonary or systemic congestion. We propose revised stages of HF as: At-risk for HF (Stage A) , for patients at risk for HF but without current or prior symptoms or signs of HF and without structural or biomarkers evidence of heart disease. Pre-heart failure (Stage B) for patients without current or prior symptoms or signs of HF but evidence of structural heart disease or abnormal cardiac function, or elevated natriuretic peptide levels. HF (Stage C) for patients with current or prior symptoms and/or signs of HF caused by a structural and/or functional cardiac abnormality. Advanced HF (Stage D) for patients with severe symptoms and/ or signs of HF at rest, recurrent hospitalizations despite guideline-directed management and therapy (GDMT) , refractory or intolerant to GDMT, requiring advanced therapies such as consideration for transplant, mechanical circulatory support, or palliative care. Finally, we propose a new and revised classification of HF according to left ventricular ejection fraction (LVEF) . The classification includes HF with reduced EF (HFrEF) : HF with LVEF ≤ 40%; HF with mid-range EF (HFmrEF) : HF with LVEF 41-49%; HF with preserved EF (HFpEF) : HF with LVEF ≥ 50%; and HF with improved EF (HFimpEF) : HF with a baseline LVEF ≤ 40%, a ≥ 10 point increase from baseline LVEF, and a second measurement of LVEF > 40.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
Self-citationVestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Self-citationEmpagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Self-citationHeart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911303 · Cited by 7,140
Self-citationAngiotensin-neprilysin inhibition versus enalapril in heart failure
McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409077 · Cited by 6,957
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Wiviott, S. D., Raz, I., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Silverman, M. G., Zelniker, T. A., Kuder, J. F., Murphy, S. A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812389 · Cited by 6,382
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Fourth universal definition of myocardial infarction (2018)
Thygesen, K., Alpert, J. S., Jaffe, A. S., Chaitman, B. R., Bax, J. J., Morrow, D. A., White, H. D., ESC Scientific Document Group, Thygesen, K., Alpert, J. S., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy462 · Cited by 5,880
Self-citationCardiovascular and renal outcomes with empagliflozin in heart failure
Packer, M., Anker, S. D., Butler, J., Filippatos, G., Pocock, S. J., Carson, P., Januzzi, J., Verma, S., Tsutsui, H., Brueckmann, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022190 · Cited by 5,206
Self-citationPitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Fourth Universal Definition of Myocardial Infarction (2018)
Thygesen, K., Alpert, J. S., Jaffe, A. S., Chaitman, B. R., Bax, J. J., Morrow, D. A., White, H. D., & The Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction (2018) · Circulation · doi:10.1161/cir.0000000000000617 · Cited by 3,799
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
Maron, B. J., Towbin, J. A., Thiene, G., Antzelevitch, C., Corrado, D., Arnett, D., Moss, A. J., Seidman, C. E., & Young, J. B. (2006) · Circulation · doi:10.1161/circulationaha.106.174287 · Cited by 3,436
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.025 · Cited by 3,418
Self-citationNishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.011 · Cited by 3,339
Heidenreich, P. A., Trogdon, J. G., Khavjou, O. A., Butler, J., Dracup, K., Ezekowitz, M. D., Finkelstein, E. A., Hong, Y., Johnston, S. C., Khera, A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820a55f5 · Cited by 3,208
Self-citationYancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000509 · Cited by 3,109
Self-citationElliott, P., Andersson, B., Arbustini, E., Bilinska, Z., Cecchi, F., Charron, P., Dubourg, O., Kuhl, U., Maisch, B., McKenna, W. J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm342 · Cited by 3,010
Spironolactone for heart failure with preserved ejection fraction
Pitt, B., Pfeffer, M. A., Assmann, S. F., Boineau, R., Anand, I. S., Claggett, B., Clausell, N., Desai, A. S., Diaz, R., Fleg, J. L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313731 · Cited by 2,809
January, C. T., Wann, L. S., Calkins, H., Chen, L. Y., Cigarroa, J. E., Cleveland, J. C., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., Furie, K. L., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000665 · Cited by 2,744
Self-citationNishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000503 · Cited by 2,497
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Solomon, S. D., McMurray, J. J. V., Anand, I. S., Ge, J., Lam, C. S. P., Maggioni, A. P., Martinez, F., Packer, M., Pfeffer, M. A., Pieske, B., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1908655 · Cited by 2,430
Self-citationThe progression from hypertension to congestive heart failure
Levy, D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530440037034 · Cited by 2,155
Julian, D. G., Moss, A. J., Murray, G. D., Poole-Wilson, P. A., Simoons, M. L., Ball, S., Bender, N., Cleland, J. G. F., Dl, C., Pj, C., et al. (1993) · PubMed · Cited by 2,144
Pfeffer, M. A., Swedberg, K., Granger, C. B., Held, P., McMurray, J. J., Michelson, E. L., Olofsson, B., Östergren, J., & Yusuf, S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14282-1 · Cited by 1,889
Julian, D. G., Moss, A. J., Murray, G. D., Poole-Wilson, P. A., Simoons, M. L., Ball, S., Bender, N., Cleland, J. G. F., Dl, C., Pj, C., et al. (1993) · The Lancet · Cited by 1,860
Inker, L. A., Astor, B. C., Fox, C. H., Isakova, T., Lash, J. P., Peralta, C. A., Kurella Tamura, M., & Feldman, H. I. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.01.416 · Cited by 1,779
Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy
Felker, G. M., Thompson, R. E., Hare, J. M., Hruban, R. H., Clemetson, D. E., Howard, D. L., Baughman, K. L., & Kasper, E. K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004133421502 · Cited by 1,723
Self-citationCommittee Members, Hunt, S. A., Baker, D. W., Chin, M. H., Cinquegrani, M. P., Feldmanmd, A. M., Francis, G. S., Ganiats, T. G., Goldstein, S., Gregoratos, G., et al. (2001) · Circulation · doi:10.1161/hc4901.102568 · Cited by 1,442
Vericiguat in patients with heart failure and reduced ejection fraction
Armstrong, P. W., Pieske, B., Anstrom, K. J., Ezekowitz, J., Hernandez, A. F., Butler, J., Lam, C. S. P., Ponikowski, P., Voors, A. A., Jia, G., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915928 · Cited by 1,358
Self-citationPredicting survival in heart failure: a risk score based on 39 372 patients from 30 studies
Pocock, S. J., Ariti, C. A., McMurray, J. J. V., Maggioni, A., Køber, L., Squire, I. B., Swedberg, K., Dobson, J., Poppe, K. K., Whalley, G. A., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs337 · Cited by 1,331
Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction
Shah, S. J., Katz, D. H., Selvaraj, S., Burke, M. A., Yancy, C. W., Gheorghiade, M., Bonow, R. O., Huang, C.-C., & Deo, R. C. (2015) · Circulation · doi:10.1161/circulationaha.114.010637 · Cited by 1,157
Self-citationMartin, P., DiMartini, A., Feng, S., Brown, R., & Fallon, M. (2014) · Hepatology · doi:10.1002/hep.26972 · Cited by 1,045
Baran, D. A., Grines, C. L., Bailey, S., Burkhoff, D., Hall, S. A., Henry, T. D., Hollenberg, S. M., Kapur, N. K., O'Neill, W., Ornato, J. P., et al. (2019) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.28329 · Cited by 1,017
Chioncel, O., Lainscak, M., Seferovic, P. M., Anker, S. D., Crespo-Leiro, M. G., Harjola, V.-P., Parissis, J., Laroche, C., Piepoli, M. F., Fonseca, C., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.813 · Cited by 927
Self-citationBozkurt, B., Colvin, M., Cook, J., Cooper, L. T., Deswal, A., Fonarow, G. C., Francis, G. S., Lenihan, D., Lewis, E. F., McNamara, D. M., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000455 · Cited by 891
Self-citationMueller, C., McDonald, K., de Boer, R. A., Maisel, A., Cleland, J. G. F., Kozhuharov, N., Coats, A. J. S., Metra, M., Mebazaa, A., Ruschitzka, F., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1494 · Cited by 804
Self-citationINTERMACS Profiles of Advanced Heart Failure: The Current Picture
Stevenson, L. W., Pagani, F. D., Young, J. B., Jessup, M., Miller, L., Kormos, R. L., Naftel, D. C., Ulisney, K., Desvigne-Nickens, P., & Kirklin, J. K. (2009) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2009.02.015 · Cited by 793
Acute Heart Failure Syndromes: Current State and Framework for Future Research
Gheorghiade, M., Zannad, F., Sopko, G., Klein, L., Piña, I. L., Konstam, M. A., Massie, B. M., Roland, E., Targum, S., Collins, S. P., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.590091 · Cited by 763
Self-citationSaunders, J. T., Nambi, V., de Lemos, J. A., Chambless, L. E., Virani, S. S., Boerwinkle, E., Hoogeveen, R. C., Liu, X., Astor, B. C., Mosley, T. H., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.005264 · Cited by 755
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
Hicks, K. A., Mahaffey, K. W., Mehran, R., Nissen, S. E., Wiviott, S. D., Dunn, B., Solomon, S. D., Marler, J. R., Teerlink, J. R., Farb, A., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.033502 · Cited by 750
Self-citationBraunwald, E. (2013) · JACC: Heart Failure · doi:10.1016/j.jchf.2012.10.002 · Cited by 730
deFilippi, C. R., de Lemos, J. A., Christenson, R. H., Gottdiener, J. S., Kop, W. J., Zhan, M., & Seliger, S. L. (2010) · JAMA · doi:10.1001/jama.2010.1708 · Cited by 715
Tsutsui, H., Isobe, M., Ito, H., Ito, H., Okumura, K., Ono, M., Kitakaze, M., Kinugawa, K., Kihara, Y., Goto, Y., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0342 · Cited by 704
Self-citationVaduganathan, M., Claggett, B. L., Jhund, P. S., Cunningham, J. W., Pedro Ferreira, J., Zannad, F., Packer, M., Fonarow, G. C., McMurray, J. J. V., & Solomon, S. D. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30748-0 · Cited by 672
Self-citationLedwidge, M., Gallagher, J., Conlon, C., Tallon, E., O’Connell, E., Dawkins, I., Watson, C., O’Hanlon, R., Bermingham, M., Patle, A., et al. (2013) · JAMA · doi:10.1001/jama.2013.7588 · Cited by 664
Cleland, J. G. F., Bunting, K. V., Flather, M. D., Altman, D. G., Holmes, J., Coats, A. J. S., Manzano, L., McMurray, J. J. V., Ruschitzka, F., van Veldhuisen, D. J., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx564 · Cited by 659
Self-citationCardiac myosin activation with omecamtiv mecarbil in systolic heart failure
Teerlink, J. R., Diaz, R., Felker, G. M., McMurray, J. J. V., Metra, M., Solomon, S. D., Adams, K. F., Anand, I., Arias-Mendoza, A., Biering-Sørensen, T., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2025797 · Cited by 656
Self-citationHalliday, B. P., Wassall, R., Lota, A. S., Khalique, Z., Gregson, J., Newsome, S., Jackson, R., Rahneva, T., Wage, R., Smith, G., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32484-x · Cited by 655
Chioncel, O., Mebazaa, A., Harjola, V.-P., Coats, A. J., Piepoli, M. F., Crespo-Leiro, M. G., Laroche, C., Seferovic, P. M., Anker, S. D., Ferrari, R., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.890 · Cited by 580
Self-citationCardiomyopathy of Overload: A Major Determinant of Prognosis in Congestive Heart Failure
Epstein, F. H., & Katz, A. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001113220206 · Cited by 564
Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure
Solomon, S. D., Vaduganathan, M., L. Claggett, B., Packer, M., Zile, M., Swedberg, K., Rouleau, J., A. Pfeffer, M., Desai, A., H. Lund, L., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044586 · Cited by 551
Solomon, S. D., Claggett, B., Lewis, E. F., Desai, A., Anand, I., Sweitzer, N. K., O'Meara, E., Shah, S. J., McKinlay, S., Fleg, J. L., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv464 · Cited by 532
Ammar, K. A., Jacobsen, S. J., Mahoney, D. W., Kors, J. A., Redfield, M. M., Burnett, J. C., & Rodeheffer, R. J. (2007) · Circulation · doi:10.1161/circulationaha.106.666818 · Cited by 522
Bozkurt, B., Aguilar, D., Deswal, A., Dunbar, S. B., Francis, G. S., Horwich, T., Jessup, M., Kosiborod, M., Pritchett, A. M., Ramasubbu, K., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000450 · Cited by 522
Self-citationCarvedilol for Prevention of Chemotherapy-Related Cardiotoxicity
Avila, M. S., Ayub-Ferreira, S. M., de Barros Wanderley, M. R., das Dores Cruz, F., Gonçalves Brandão, S. M., Rigaud, V. O. C., Higuchi-dos-Santos, M. H., Hajjar, L. A., Kalil Filho, R., Hoff, P. M., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.049 · Cited by 507
Titration of medical therapy for heart failure with reduced ejection fraction
Greene, S. J., Fonarow, G. C., DeVore, A. D., Sharma, P. P., Vaduganathan, M., Albert, N. M., Duffy, C. I., Hill, C. L., McCague, K., Patterson, J. H., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.02.015 · Cited by 500
Self-citationMedical Management of Advanced Heart Failure
Nohria, A. (2002) · JAMA · doi:10.1001/jama.287.5.628 · Cited by 465
Atherton, J. J., Sindone, A., De Pasquale, C. G., Driscoll, A., MacDonald, P. S., Hopper, I., Kistler, P. M., Briffa, T., Wong, J., Abhayaratna, W., et al. (2018) · Heart, Lung and Circulation · doi:10.1016/j.hlc.2018.06.1042 · Cited by 431
Self-citationLund, L. H., Claggett, B., Liu, J., Lam, C. S., Jhund, P. S., Rosano, G. M., Swedberg, K., Yusuf, S., Granger, C. B., Pfeffer, M. A., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1149 · Cited by 430
Self-citation(2015) · doi:10.1002/ejhf.289 · Cited by 417
Self-citationvan Veldhuisen, D. J., Linssen, G. C. M., Jaarsma, T., van Gilst, W. H., Hoes, A. W., Tijssen, J. G. P., Paulus, W. J., Voors, A. A., & Hillege, H. L. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.12.044 · Cited by 414
Hollenberg, S. M., Warner Stevenson, L., Ahmad, T., Amin, V. J., Bozkurt, B., Butler, J., Davis, L. L., Drazner, M. H., Kirkpatrick, J. N., Peterson, P. N., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.08.001 · Cited by 336
Self-citationTsuji, K., Sakata, Y., Nochioka, K., Miura, M., Yamauchi, T., Onose, T., Abe, R., Oikawa, T., Kasahara, S., Sato, M., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.807 · Cited by 329
Self-citationHeart Failure With Recovered Left Ventricular Ejection Fraction
Wilcox, J. E., Fang, J. C., Margulies, K. B., & Mann, D. L. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.075 · Cited by 322
Vedin, O., Lam, C. S. P., Koh, A. S., Benson, L., Teng, T. H. K., Tay, W. T., Braun, O. Ö., Savarese, G., Dahlström, U., & Lund, L. H. (2017) · Circulation: Heart Failure · doi:10.1161/circheartfailure.117.003875 · Cited by 289
Self-citationLam, C. S. P., Gamble, G. D., Ling, L. H., Sim, D., Leong, K. T. G., Yeo, P. S. D., Ong, H. Y., Jaufeerally, F., Ng, T. P., Cameron, V. A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy005 · Cited by 288
Self-citationAnker, S. D., Butler, J., Filippatos, G. S., Jamal, W., Salsali, A., Schnee, J., Kimura, K., Zeller, C., George, J., Brueckmann, M., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1596 · Cited by 250
Self-citationPellikka, P. A., She, L., Holly, T. A., Lin, G., Varadarajan, P., Pai, R. G., Bonow, R. O., Pohost, G. M., Panza, J. A., Berman, D. S., et al. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.1456 · Cited by 238 · cited 1×
“Although other cardiovascular imaging modalities can be used to assess EF, there is substantial variation between modalities as well.(53) Furthermore, EF is not a reliable measure of contractile performance, is load dependent, and can vary according to hemodynamic status and loading conditions.”
BackgroundThe MOGE(S) Classification of Cardiomyopathy for Clinicians
Arbustini, E., Narula, N., Tavazzi, L., Serio, A., Grasso, M., Favalli, V., Bellazzi, R., Tajik, J. A., Bonow, R. O., Fuster, V., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.027 · Cited by 224
Writing Committee Members, Bonow, R. O., Ganiats, T. G., Beam, C. T., Blake, K., Casey, D. E., Goodlin, S. J., Grady, K. L., Hundley, R. F., Jessup, M., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182507bec · Cited by 185
Gislason, G. H., Rasmussen, J. N., Abildstrom, S. Z., Schramm, T. K., Hansen, M. L., Buch, P., Sørensen, R., Folke, F., Gadsbøll, N., Rasmussen, S., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.669101 · Cited by 183
Seid, M. A., Abdela, O. A., & Zeleke, E. G. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211768 · Cited by 165
Cheng, S., Claggett, B., Correia, A. W., Shah, A. M., Gupta, D. K., Skali, H., Ni, H., Rosamond, W. D., Heiss, G., Folsom, A. R., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.008506 · Cited by 160
Zheng, S. L., Chan, F., Nabeebaccus, A., Shah, A. M., McDonagh, T. A., Okonko, D. O., & Ayis, S. A. (2017) · Heart · doi:10.1136/heartjnl-2017-311652 · Cited by 156
Berg, D. D., Wiviott, S. D., Scirica, B. M., Gurmu, Y., Mosenzon, O., Murphy, S. A., Bhatt, D. L., Leiter, L. A., McGuire, D. K., Wilding, J. P. H., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.042685 · Cited by 154
Outpatient Worsening Heart Failure as a Target for Therapy: A Review
Greene, S. J., Mentz, R. J., & Felker, G. M. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2017.5250 · Cited by 152
Self-citationRastogi, A., Novak, E. L., Platts, A. E., & Mann, D. L. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.879 · Cited by 140
Heart failure with preserved ejection fraction: controversies, challenges and future directions
Zakeri, R., & Cowie, M. (2018) · Heart · doi:10.1136/heartjnl-2016-310790 · Cited by 123
Efficacy of Sacubitril/Valsartan Relative to a Prior Decompensation
Solomon, S. D., Claggett, B. L., Packer, M., Desai, A., Zile, M. R., Swedberg, K. B., Rouleau, J. L., Shi, V. C., Lefkowitz, M. P., & McMurray, J. J. V. (2016) · JACC Heart Failure · doi:10.1016/j.jchf.2016.05.002 · Cited by 111
Comparison of Approaches for Heart Failure Case Identification From Electronic Health Record Data
Blecker, S., Katz, S. D., Horwitz, L. I., Kuperman, G. J., Park, H., Gold, A., & Sontag, D. A. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.3236 · Cited by 103
Risk Profiles in Heart Failure: Baseline, Residual, Worsening, and Advanced Heart Failure Risk
Greene, S. J., Fonarow, G. C., & Butler, J. (2020) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.007132 · Cited by 90
Self-citationThe defintion of heart failure
Dénolin, H., Kuhn, H. J., Krayenbuehl, H. P., Loogen, F., & REALE, A. (1983) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a061500 · Cited by 89
So many definitions of heart failure: are they all universally valid? A critical appraisal
Tan, L., Williams, S. G., Tan, D. K., & Solal, A. C. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.187 · Cited by 88
Natriuretic Peptides as Inclusion Criteria in Clinical Trials
Ibrahim, N. E., Burnett, J. C. J., Butler, J., Camacho, A., Felker, G. M., Fiuzat, M., O’Connor, C. J., Solomon, S. D., Vaduganathan, M., Zile, M. R., et al. (2020) · JACC Heart Failure · doi:10.1016/j.jchf.2019.12.010 · Cited by 88
Self-citationProgression of preclinical diastolic dysfunction to the development of symptoms
de, D. D. C., Hodge, D. O., Slusser, J. P., Redfield, M. M., Simari, R. D., Burnett, J. C., & Chen, H. (2010) · Heart · doi:10.1136/hrt.2009.177980 · Cited by 81
Silent Disease Progression in Clinically Stable Heart Failure
Sabbah, H. N. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.705 · Cited by 80
Recognizing Worsening Chronic Heart Failure as an Entity and an End Point in Clinical Trials
Butler, J., Braunwald, E., & Gheorghiade, M. (2014) · JAMA · doi:10.1001/jama.2014.6643 · Cited by 79
Self-citationThe MELD-Plus: A generalizable prediction risk score in cirrhosis
Kartoun, U., Corey, K. E., Simon, T. G., Zheng, H., Aggarwal, R., Ng, K., & Shaw, S. Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186301 · Cited by 77
Heidenreich, P. A., Fonarow, G. C., Breathett, K. K., Jurgens, C. Y., Pisani, B., Pozehl, B., Spertus, J. A., Taylor, K. G., Thibodeau, J. T., Yancy, C. W., et al. (2020) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/hcq.0000000000000099 · Cited by 70
Self-citationSymptom perception in heart failure: a scoping review on definition, factors and instruments
Santos, G. C., Liljeroos, M., Dwyer, A. A., Jaques, C., Girard, J., Strömberg, A., Hullin, R., & Schäfer‐Keller, P. (2019) · European Journal of Cardiovascular Nursing · doi:10.1177/1474515119892797 · Cited by 68
Design of Therapy for Advanced Heart Failure
Stevenson, L. W. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.01.004 · Cited by 66
Dapagliflozin for Heart Failure with Preserved Ejection Fraction: Will the DELIVER Study Deliver?
Williams, D. M., & Evans, M. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00911-0 · Cited by 62
2021 ACC/AHA Key Data Elements and Definitions for Heart Failure
Bozkurt, B., Hershberger, R. E., Butler, J., Grady, K. L., Heidenreich, P. A., Isler, M. L., Kirklin, J. K., & Weintraub, W. S. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.012 · Cited by 61
Self-citationMorbach, C., Gelbrich, G., Tiffe, T., Eichner, F. A., Christa, M., Mattern, R., Breunig, M., Cejka, V., Wagner, M., Heuschmann, P. U., et al. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487320922636 · Cited by 57
Wagner, M., Tiffe, T., Morbach, C., Gelbrich, G., Störk, S., & Heuschmann, P. U. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316680693 · Cited by 56
Prevalence of Lactic Acidaemia in Patients with Advanced Heart Failure and Depressed Cardiac Output
Adamo, L., Nassif, M. E., Novak, E., LaRue, S., & Mann, D. L. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.628 · Cited by 53
Endpoints in Heart Failure Drug Development
Fiuzat, M., Lowy, N., Stockbridge, N., Sbolli, M., Latta, F., Lindenfeld, J., Lewis, E. F., Abraham, W. T., Teerlink, J. R., Walsh, M. N., et al. (2020) · JACC Heart Failure · doi:10.1016/j.jchf.2019.12.011 · Cited by 53
Self-citationReasons for Lack of Improvement in Treatment With Evidence-Based Therapies in Heart Failure
Bozkurt, B. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.464 · Cited by 49
Self-citationLinde, C. M., Curtis, A. B., Fonarow, G. C., Lee, K. L., Little, W. C., TANG, A. S. L., Levya, F., Momomura, S., Manrodt, C., Bergemann, T. L., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.09.023 · Cited by 37
Self-citationWagner, S. (1977) · Archives of Internal Medicine · doi:10.1001/archinte.1977.03630170075017 · Cited by 29
Heart failure. A proposed definition and classification
Wagner, S. (1977) · Archives of Internal Medicine · doi:10.1001/archinte.137.5.675 · Cited by 25
Ejection fraction in heart failure revisited- where does the evidence start?
Böhm, M., Bewarder, Y., & Kindermann, I. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa281 · Cited by 22
Self-citationBozkurt, B., & Ezekowitz, J. A. (2020) · Circulation · doi:10.1161/circulationaha.120.045008 · Cited by 19
Self-citationPrevention or Procrastination for Heart Failure?
Cleland, J. G. F., Pellicori, P., & Clark, A. L. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.471 · Cited by 17
Disparities in Heart Failure Care
Pinney, S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.07.008 · Cited by 11
The problem of defining heart failure
Harris, P. C. (1994) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00877921 · Cited by 6
Cited by
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
Self-citation2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
Self-citationHeart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America
Bozkurt, B., Ahmad, T., Alexander, K. M., Baker, W. L., Bosak, K., Breathett, K., Fonarow, G. C., Heidenreich, P., Ho, J. E., Hsich, E., et al. (2023) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2023.07.006 · Cited by 695
Self-citationSarcopenia and Cardiovascular Diseases
Damluji, A. A., Alfaraidhy, M., AlHajri, N., Rohant, N. N., Kumar, M., Al Malouf, C., Bahrainy, S., Ji Kwak, M., Batchelor, W. B., Forman, D. E., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.064071 · Cited by 645
Filippatos, G., Anker, S. D., Agarwal, R., Ruilope, L. M., Rossing, P., Bakris, G. L., Tasto, C., Joseph, A., Kolkhof, P., Lage, A., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.057983 · Cited by 299
Self-citation
Metadata
- Authors
- Bozkurt, B., Coats, A. J., Tsutsui, H., Abdelhamid, M., Adamopoulos, S., Albert, N., Anker, S. D., Atherton, J., Böhm, M., Butler, J., Drazner, M. H., Felker, G. M., Filippatos, G., Fonarow, G. C., Fiuzat, M., Gomez-Mesa, J., Heidenreich, P., Imamura, T., Januzzi, J., Jankowska, E. A., Khazanie, P., Kinugawa, K., Lam, C. S. P., Matsue, Y., Metra, M., Ohtani, T., Francesco Piepoli, M., Ponikowski, P., Rosano, G. M. C., Sakata, Y., SeferoviĆ, P., Starling, R. C., Teerlink, J. R., Vardeny, O., Yamamoto, K., Yancy, C., Zhang, J., & Zieroth, S.
- Venue
- Journal of Cardiac Failure
- Publisher
- Elsevier BV
- Published
- 2021-04
- Volume
- 27
- Issue
- 4
- Pages
- 387-413
- ISSN
- 1071-9164 (ISSN-L)
- OpenAlex
- W3133511216
- Cited by
- 995
- References
- 112
- FWCI
- 88.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.